News

27/08/2020
HBV: seroconversion does not improve T cell responses
New results on the effect of seroconversion on the natural history and treatment of chronic hepatitis b
MORE
06/08/2020
Else Kröner Fresenius Prize for biomedical research to Alessandro Aiuti
The Deputy Director of the San Raffaele-Telethon Institute for Gene Therapy in Milan awarded for his contribution to the development of innovative therapies for serious genetic diseases.
MORE
03/06/2020
AI-SCORE, a project to calculate prognostic risk from Covid-19
An artificial intelligence project is born from the partnership between San Raffaele, Microsoft and NVIDIA and will allow to distinguish those patients that infected with Sars-Cov-2 will develop the most serious form of the pathology
MORE
26/05/2020
Comparison study between tocilizumab and standard treatment in COVID-19
The study tested the safety and efficacy of the immunosuppressive drug and compared the results to patients treated only with standard therapy
MORE